Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDCO-216 in recent acute coronary syndrome
NCT02678923Phase 2Completed
- Sponsor
- The Medicines Company
- Start
- Dec 2015
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 2 trial of apolipoprotein A-I Milano in acute coronary syndrome (ACS), sponsored by The Medicines Company. Started Dec 2015; status: completed.
02
Drugs
apolipoprotein A-I Milano
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02678923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678923.